Researchers at Cedars-Sinai have unlocked the mystery of how an inflammatory molecule is produced in the body, a discovery they say could lead to advances in the treatment of rheumatoid arthritis, Type 2 diabetes and numerous other chronic diseases that affect tens of millions of people. The researchers identified the mechanism that leads to the production of the molecule interleukin-1beta. Current therapies seek to block this molecule's action after it is secreted by cells. However, the ...
↧